Pancreatic Cancer Progress
When anything in the body goes into overdrive, trouble usually follows. Genes that are switched to and stay “on” all the time can lead to cancer. A molecular pathway that behaves this way may be a new target for a tough cancer.
Can This Cancer Be Blamed On Fat Cells?
How and why pancreatic cancer develops has never been clearly understood. New clues are emerging, though, that could help diagnose and treat this cancer.
End Caps and Pancreatic Cancer
Trying to predict who’s at risk for cancer is a key research goal. Scientists look at all sorts of things to do this. Science is making progress in predicting pancreatic cancer risk.
Cancer Proves Too Much For Experimental Rx
The theory was solid but, as is so often the case – unfortunately – the experimental drug just didn’t deliver. A phase II trial showed that a new type of chemotherapy wasn’t effective against pancreatic cancer.
New Era In Cancer Treatment?
The outlook for people diagnosed with pancreatic cancer has just brightened a little. Scientists have made a giant leap forward in understanding the background operations of this cancer.
More Risks For BRCA Carriers
Genetic mutations are often the root cause of some cancers. Some of these changes are inherited. Altered BRCA1 and BRCA2 genes, for example, increase risks for breast cancer.
Abraxane Shows Positive Progress for Pancreatic Cancer Treatment
Celgene International Sàrl, a subsidiary of Celgene Corporation today announced that its phase III study of Abraxane (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with gemcitabine in treatment-naïve patients with advanced pancreatic cancer met its primary endpoint of overall survival.
One Cancer That’s Actually Many Cancers
Scientists are increasingly realizing that a specific type of cancer is actually many different diseases. A new study has confirmed this is certainly the case with pancreatic cancer.
What 132 Billion Data Points Per Patient Mean
Whole genome sequencing, or WGS , spells out all 3 billion letters in the human genome. It’s being used now to learn more about pancreatic cancer, and the findings may change the outlook for this disease.
Smokers and Drinkers Diagnosed With Cancer Earlier
Pancreatic cancer is not a good one. Medical scientists don’t know what causes this cancer, with the exception of rare genetic links. And there’s no screening for the healthy general population. A recent study sheds light on risk factors.